Image credit: Jeremy Buckingham

Advil-Maker GlaxoSmithKline Among Entities Newly Lobbying on Cannabis

From CBD and banking legislation in Congress to the right to advertise in legal states, here are the entities newly lobbying on cannabis-related issues at the national level.

Lobbying
New York

New York’s Cannabis Equity Fund Recalibrates: “The Markets Have Changed” 

Cannabis regulators met on Tuesday for the second time in May to also approve emergency enforcement rules and a settlement related to a lawsuit that blocked licensing in parts of the state.

Regulation

As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.